|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-5-18
|
|
pubmed:abstractText |
The high density lipoprotein Anionic Peptide Factor (HDL(3)-APF) was previously described as an apolipoprotein that promotes the reverse cholesterol transport. Since phospholipid transfer protein (PLTP) is involved in such mechanism we attempted to focus on the two APF and PLTP proteins.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1873-2933
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
845-51
|
|
pubmed:meshHeading |
pubmed-meshheading:19135989-Adult,
pubmed-meshheading:19135989-Aged,
pubmed-meshheading:19135989-Apoproteins,
pubmed-meshheading:19135989-Calcium-Binding Proteins,
pubmed-meshheading:19135989-Coronary Artery Disease,
pubmed-meshheading:19135989-Diabetes Mellitus, Type 2,
pubmed-meshheading:19135989-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19135989-Humans,
pubmed-meshheading:19135989-Middle Aged,
pubmed-meshheading:19135989-Phospholipid Transfer Proteins
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
|
|
pubmed:affiliation |
Laboratoire de Biochimie, UR Nutrition et Désordres Métaboliques Faculté de médecine, Monastir, Tunisia. Nabil.Attia@fsb.rnu.tn
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
